Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|July 11, 2022
Arginase: Mechanisms and Clinical Application in Hematologic MalignancyZefan Du, Tianwen Li, Junbin Huang, et al.Frontiers in Oncology|May 4, 2023
Ferroptosis in hematological malignant tumorsYong Liu, Zefan Du, Junbin Huang, et al.Frontiers in Genetics|January 26, 2023
Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemiaYong Liu, Jing Zhang, Zefan Du, et al.Oncology Research|June 3, 2024
Preclinical evaluation of cyclophosphamide and fludarabine combined with CD19 CAR-T in the treatment of B-cell hematologic malignancies in vivoZhigang Xia, Mengyao Tian, Yucai Cheng, et al.Carcinogenesis|May 31, 2024
Antitumor activity of niclosamide-mediated oxidative stress against acute lymphoblastic leukemiaJing Yang, Yong Liu, Zefan Du, et al.Biomedicines|July 29, 2025
Advances and Challenges in Targeted Therapy and Its Combination Strategies for LeukemiaZhiyuan Zhong, Ran Yao, Yifei Duan, et al.European Journal of Pharmacology|November 11, 2023
Lycorine eliminates B-cell acute lymphoblastic leukemia cells by targeting PSAT1 through the serine/glycine metabolic pathwayYong Liu, Zefan Du, Tianwen Li, et al.Experimental Hematology & Oncology|July 3, 2025
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapyYong Liu, Yifei Duan, Zefan Du, et al.Frontiers in Immunology|June 19, 2026
Integrative multi-omics reveals that downregulation of HLA-DPA1/DPB1 drives macrophage immune-metabolic dysregulation in pediatric asthmaYuchen Wen, Zefan Du, Zhiyuan Zhong, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 5, 2026
NSUN2 as a therapeutic target: Modulating tumor growth and immune microenvironment in colon adenocarcinomaYuchen Wen, Mengjun Huang, Haoyu Fu, et al.Pageof 2